Real world safety of Alemtuzumab in the treatment of Multiple Sclerosis - Australian cohort study

被引：0
|
作者：
Corbett, Joel [1 ]
Blum, Stefan [2 ]
Boggild, Mike [1 ]
Broadley, Simon [3 ]
McCombe, Pamela [4 ]
机构：
[1] Townsville Hosp, Townsville, Qld, Australia
[2] Princess Alexandra Hosp, Harlow, Essex, England
[3] Griffith Univ, Sch Med, Nathan, Qld, Australia
[4] Royal Brisbane & Womens Hosp, Herston, Qld, Australia
来源：
NEUROLOGY | 2020年 / 94卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
1499
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Efficacy and safety of alemtuzumab treatment in a real-world cohort of patients with multiple sclerosis
    Zmira, Ofir
    Halpern, Alex, I
    Abraham, Lital
    Achiron, Anat
    [J]. ACTA NEUROLOGICA BELGICA, 2021, 121 (06) : 1513 - 1518
  • [2] Efficacy and safety of alemtuzumab treatment in a real-world cohort of patients with multiple sclerosis
    Ofir Zmira
    Alex I. Halpern
    Lital Abraham
    Anat Achiron
    [J]. Acta Neurologica Belgica, 2021, 121 : 1513 - 1518
  • [3] Results of treatment with alemtuzumab in a Spanish cohort of patients with multiple sclerosis in the real world: The RealMS study
    Eichau, Sara
    Ruiz, Rocio Lopez
    de Arcos, Maria Ruiz
    Ruiz-Pena, Juan Luis
    Navarro, Guillermo
    Calleja, Miguel Angel
    Moreno-Amador, Jose Luis
    Garcia-Soto, Julio Dotor
    [J]. FRONTIERS IN NEUROLOGY, 2023, 14
  • [4] Real-World Alemtuzumab Efficacy and Safety in a Multiple Sclerosis Patient Population: A Single-Center Cohort Study
    Kalligianni-Sofikiti, M. -E.
    Mastorodemos, V.
    Mitsias, P.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 923 - 923
  • [5] Safety issues in multiple sclerosis patients treated with alemtuzumab in real world
    Oreja-Guevara, C.
    Guerra-Schulz, E.
    Minano-Guillamon, E.
    Carcamo Fonfria, A.
    Ortiz-Pica, M.
    Arenaza-Pena, A.
    Gonzalez-Suarez, I.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 920 - 921
  • [6] Efficacy and safety of alemtuzumab in a real-life cohort of patients with multiple sclerosis
    Frau, Jessica
    Coghe, Giancarlo
    Lorefice, Lorena
    Fenu, Giuseppe
    Musu, Luigina
    Cocco, Eleonora
    [J]. JOURNAL OF NEUROLOGY, 2019, 266 (06) : 1405 - 1411
  • [7] Efficacy and safety of alemtuzumab in a real-life cohort of patients with multiple sclerosis
    Jessica Frau
    Giancarlo Coghe
    Lorena Lorefice
    Giuseppe Fenu
    Luigina Musu
    Eleonora Cocco
    [J]. Journal of Neurology, 2019, 266 : 1405 - 1411
  • [8] A real-world cohort analysis of alemtuzumab outcomes in relapsing multiple sclerosis
    Herman, Jorge Acevedo
    Khalighinejad, Farnaz
    York, Katherine
    Radu, Irina
    Morales, Idanis Berrios
    Ionete, Carolina
    Hemond, Christopher C.
    [J]. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 47
  • [9] REAL WORLD EXPERIENCE OF TREATING MULTIPLE SCLEROSIS WITH ALEMTUZUMAB
    Khalili, Ellie
    Venning, Brent
    Boggild, Mike
    Broadley, Simon A.
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2018, 89 (06): : E33 - E33
  • [10] Safety of alemtuzumab in a nationwide cohort of Finnish multiple sclerosis patients
    Ilkka Rauma
    Tiina Mustonen
    Juha Matti Seppä
    Maritta Ukkonen
    Marianne Männikkö
    Auli Verkkoniemi-Ahola
    Marge Kartau
    Jukka T. Saarinen
    Liisa Luostarinen
    Sakari Simula
    Mervi Ryytty
    Riitta Ahmasalo
    Jussi O. T. Sipilä
    Ilkka Pieninkeroinen
    Tero Tapiola
    Anne M. Remes
    Hanna Kuusisto
    [J]. Journal of Neurology, 2022, 269 : 824 - 835
12345